ST. PAUL, Minn., Sept. 16, 2024 /PRNewswire/ -- ScaleReady and Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of the G-Rex optimized ProPakTM GMP Cytokines, ideally tailored to high efficiency closed system cell and gene-modified cell therapy (CGT) manufacturing.The ProPakTM GMP Cytokine product consists of a weldable bag filled with liquid formulated GMP-grade cytokines, specifically interleukin-7 (IL-7) or interleukin-15 (IL-15), commonly used in the ex vivo manufacturing of CAR-T and TC ...

PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), priced a private offering of $700 million aggregate principal amount of 8.250% senior notes due 2030 (the “Notes”), which represents a $200 million increase from the previously announced size of the offering. The Notes will have a maturity date of January 15, 2030. Th ...

NEWTOWN, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Avis Rent A Car System LLC (“Avis”). Avis learned of suspicious activity on or about August 5, 2024. To join this case, go HERE. About Avis Rent a Car System LLC Avis is an American car rental company headquartered in Parsippany-Troy Hills, New Jersey. What happened? On or about August 5, 2024, Avis discovered that hackers had accessed one of their business appli ...

PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $500 million aggregate principal amount of senior notes due 2030 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of ...

文章核心观点 - 艾维斯租车公司遭遇数据泄露事件,导致299,006名个人的敏感个人信息可能被黑客获取 [1][2] - 这些个人信息可能被黑客在暗网上出售或用于身份盗窃 [2] - 穆菲律师事务所正在调查此事,并考虑提起集体诉讼以代表受影响的个人追讨损失 [2] 公司相关 - 艾维斯租车公司在2024年8月5日发现其计算机网络存在可疑活动,表明遭遇数据泄露 [1] - 公司随后的取证调查发现,黑客侵入了公司的计算机系统,获取了包含299,006名个人敏感信息的数据文件 [1] - 泄露的个人信息包括姓名和其他个人身份信息 [1] 行业相关 - 此次数据泄露事件可能导致受影响个人的个人和高度敏感信息落入黑客手中 [2] - 黑客可能将这些信息在暗网上出售或用于身份盗窃等犯罪活动 [2]

Car rental giant Avis is notifying hundreds of thousands of people that their personal information and driver’s license numbers were stolen in an August cyberattack.The New Jersey-headquartered company said in a data breach notice filed with several U.S. attorneys general over the past week that it discovered intruders in one of its business applications on August 5 and took efforts to end the unauthorized access, which the company said began two days earlier.  Avis did not disclose the nature of the cyber ...

Kaan Uluer/iStock via Getty Images Note: All amounts discussed are in Canadian Dollars. Stock Prices refer to those on the TSX and not the OTC symbol. In May of this year, we switched to a Buy on Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN:CA) (“CAPREIT”) and acquired a chunk of shares. The REIT was hit with the same malaise that infected the entire Canadian sector. But unlike some distressed names, this one had no real issues, apart from a lack of investor patience. That pat ...

Reactivation of P-BCMA-101 CAR-T cells and a repeat stringent complete response (sCR) more than 3 years after original CAR-T therapyDemonstrates potential of stem cell memory T cells (TSCM), a key differentiator for Poseida's CAR-T programs SAN DIEGO, Sept. 4, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, highlighted new data from ...

SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the inventor of its ovarian cancer CAR-T technology, Jose R. Conejo-Garcia, M.D., Ph.D., Professor of Immunology in the Department of Integrative Immunobiology at the Duke University School of Medicine, will be speaking at the Rivkin Center and American Association for Cancer Research (AACR) 15th Bie ...

Descartes-15 observed to achieve an approximately ten-fold increase relative to Descartes-08 in CAR expression and selective target-specific killing in preclinical studies GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the first patient has been dosed in its first-in-human Phase 1 trial of Descartes-15, the Company’s next-genera ...